According to Lei et al. [71], the lncRNA H19 is secreted into EVs, promoting resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small-cell lung cancer cells. This evidence concerns the gene EGFR and non-small cell lung carcinoma.